ALS News Today12h
Medicare Advantage plans in US told to cover Qalsody for SOD1-ALS
The Centers for Medicare and Medicaid Services is directing all Medicare Advantage plans to cover Qalsody for treating ...
STAT5d
They agreed to cover a drug for six months — and now I have to fight for it again
Shelby Kinsey lives with a rare, fast-progressing form of ALS — but she has to spend her precious time fighting for insurance ...
Medpage Today on MSN1d
Detecting Alzheimer's Risks; Migraine and GI Disorders; CJD Glymphatic Dysfunction
(JAMA Neurology) CMS issued a directive requiring Medicare Advantage plans to provide access to tofersen (Qalsody), a ...
CMS says private Medicare plans can’t automatically deny Biogen’s ALS drug
In a rare move, the U.S. agency behind Medicare is warning Medicare Advantage providers they can’t have blanket policies that ...
Private Medicare plans must cover Biogen's ALS drug, US agency says
The Centers for Medicare & Medicaid Services has directed private insurers providing Medicare Advantage plans to cover Biogen ...
Biogen ALS drug needs to be covered by MA plans, CMS says
Medicare Advantage plans must cover Biogen’s (NASDAQ:BIIB) drug Qalsody for the treatment of ALS, according to a report. The ...
Longview News-Journal8d
Groundbreaking Directive Ensures ALS Patients on Medicare Advantage Gain Access to Qalsody
Dec. 11, 2024 /PRNewswire/ -- The Centers for Medicare & Medicaid Services (CMS) has announced a first-of-its-kind directive requiring Medicare Advantage plans to approve coverage for Qalsody ...